Table 2 Specific clinical characteristics of studied subjects
From: Role of disturbed fatty acids metabolism in the pathophysiology of diabetic erectile dysfunction
Characteristics | Patients with VED (n = 72) | Patients w/o ED (n = 78) | Controls (n = 88) |
|---|---|---|---|
Inflammatory Cytokines | |||
IL-6 (pg/mL) | 0.86 ± 0.5** | 0.51 ± 0.2 | 0.44 ± 0.3 |
TNF-α (pg/mL) | 3.3 ± 2.9** | 2.9 ± 1.9** | 1.43 ± 1.2 |
Lipid peroxidation | |||
MDA (μM) | 23.9 ± 4.5** | 18.7 ± 5.3 | 17.11 ± 5.9 |
Conjugated diene (μM) | 139.16 ± 68.4 | 141.76 ± 34.5 | 122.4 ± 55.9 |
Serum Hormones | |||
FSH (mIU/mL) | 7.22 ± 4.9 | 6.83 ± 2.6 | 6.32 ± 2.4 |
LH (mIU/mL) | 5.67 ± 3.4 | 6.14 ± 3.6 | 6.07 ± 2.1 |
PRL (ng/mL) | 12.16 ± 5.1 | 12.83 ± 4.4 | 11.19 ± 2.9 |
Testosterone (ng/mL) | 5.35 ± 1.5 | 6.12 ± 2.8 | 5.89 ± 2.1 |
FT4 (pmoL/L) | 13.92 ± 1.5 | 12.53 ± 2.6 | 13.64 ± 2.3 |
hsTSH (μIU/mL) | 1.95 ± 0.9 | 1.76 ± 0.7 | 1.83 ± 0.9 |